Driehaus Capital Management LLC Invests $10.12 Million in Semler Scientific, Inc. (NASDAQ:SMLR)

Driehaus Capital Management LLC purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 187,449 shares of the company’s stock, valued at approximately $10,122,000. Driehaus Capital Management LLC owned 2.02% of Semler Scientific at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Veery Capital LLC purchased a new stake in shares of Semler Scientific during the 4th quarter worth about $324,000. Exchange Traded Concepts LLC increased its position in shares of Semler Scientific by 345.8% in the fourth quarter. Exchange Traded Concepts LLC now owns 61,396 shares of the company’s stock valued at $3,315,000 after buying an additional 47,625 shares in the last quarter. Deltec Asset Management LLC acquired a new position in shares of Semler Scientific during the 4th quarter worth approximately $2,462,000. Principal Financial Group Inc. lifted its position in shares of Semler Scientific by 633.1% during the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock valued at $6,074,000 after buying an additional 97,144 shares in the last quarter. Finally, Sanctuary Advisors LLC grew its stake in Semler Scientific by 13.2% in the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company’s stock valued at $261,000 after acquiring an additional 584 shares during the period. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Down 1.3 %

Shares of SMLR opened at $34.79 on Friday. The firm’s fifty day moving average is $35.05 and its two-hundred day moving average is $46.46. The stock has a market cap of $333.88 million, a PE ratio of 7.09 and a beta of 1.33. Semler Scientific, Inc. has a 52-week low of $21.77 and a 52-week high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating the consensus estimate of $0.20 by $3.21. The firm had revenue of $12.41 million during the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Analyst Ratings Changes

Separately, Lake Street Capital raised their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.